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Endoplasmic reticulumstress induces ligand-independent
TNFR1-mediated necroptosis in L929 cells
S Saveljeva1,2, SL Mc Laughlin1,2, P Vandenabeele3,4, A Samali*,1,2,5 and MJM Bertrand*,3,4,5
Endoplasmic reticulum (ER) stress-induced cellular dysfunction and death is associated with several human diseases. It has been
widely reported that ER stress kills through activation of the intrinsic mitochondrial apoptotic pathway. Here we demonstrate that
ER stress can also induce necroptosis, an receptor-interacting protein kinase 1 (RIPK1)/RIPK3/mixed lineage kinase domain-like
protein (MLKL)-dependent form of necrosis. Remarkably, we observed that necroptosis induced by various ER stressors in L929
cells is dependent on tumor necrosis factor receptor 1 (TNFR1), but occurs independently of autocrine TNF or lymphotoxin
α production. Moreover, we found that repression of either TNFR1, RIPK1 or MLKL did not protect the cells from death but instead
allowed a switch to ER stress-induced apoptosis. Interestingly, while caspase inhibition was sufficient to protect TNFR1- or
MLKL-deficient cells from death, rescue of the RIPK1-deficient cells additionally required RIPK3 depletion, indicating a switch back
to RIPK3-dependent necroptosis in caspase-inhibited conditions. The finding that ER stress also induces necroptosis may open
new therapeutic opportunities for the treatment of pathologies resulting from unresolved ER stress.
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The endoplasmic reticulum (ER) has a major role in the
synthesis, folding and trafficking of secretory and membrane
proteins.1 Many cellular conditions can alter proper ER
functions. As a consequence, un- or misfolded proteins
accumulate in the ER lumen and induce ER stress. All
eukaryotic cells have developed a quality control system,
known as the unfolded protein response (UPR), to sense and
adapt to ER stress.2 In mammalian cells, the UPR emerges
from three ER-anchored receptors (inositol-requiring enzyme-
1 (IRE1), protein kinase RNA-like ER kinase (PERK) and
activating transcription factor 6) and promotes a return to ER
homeostasis by activating signaling pathways aimed at
increasing the folding capacity of the ER, reducing synthesis
of new proteins and promoting alternative forms of protein
degradation (such as ER-associated degradation and auto-
phagy). However, when ER stress is too severe and/or
prolonged, the UPR is insufficient to restore homeostasis,
and therefore turns into a toxic signal leading to cell death.3,4
Accumulating evidence indicate that ER stress-induced
cellular dysfunction and death are associated with and
contribute to several human diseases (such as neurodegen-
erative diseases, inflammation and cancer), highlighting the
need for a better understanding of the molecular mechanisms
regulating ER stress-mediated death in the hope to identify
new therapeutic targets.5–7
ER stress is widely reported to induce caspase-dependent
apoptotic cell death, and although few studies support
implication of the receptor extrinsic pathway, the vast majority
of them attribute the killing to the activation of the mitochon-
drial intrinsic pathway.4 The intrinsic apoptotic pathway relies
on the B-cell lymphoma 2 (BCL-2)-associated X protein/BCL-2
antagonist/killer-dependent mitochondrial outer membrane
permeabilization (MOMP), which causes the release of
cytochrome c into the cytoplasm and allows formation of the
apoptosome and the subsequent activation of procaspase-9.
Distinct mechanisms have been reported to induce MOMP by
modulating the expression and/or activation of the various
pro- and anti-death BCL-2 family members in conditions
of unresolved ER stress.8 Among them are the IRE1-mediated
c-Jun N-terminal kinase (JNK) activation,9 the controversial
IRE1-dependent degradation of caspase-2 targetingmiRNA10,11
or the PERK-dependent expression of the transcription factor C/
EBP-homologous protein (CHOP).12,13
Apoptosis is however not the only way for a cell to die, and
recent studies have highlighted the importance of necroptosis,
a regulated form of necrosis that relies on the enzymatic
activity of the serine/threonine receptor-interacting protein
kinase 1 (RIPK1) and RIPK3, in the pathogenesis of various
human diseases.14,15 Necroptosis has so far mainly been
studied in the context of death receptor signaling, such as
downstream of the tumor necrosis factor (TNF) receptor 1
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(TNFR1), and was shown to prevail in caspase-8-inhibited
conditions.16–18 In contrast to most cells, the murine fibrosar-
coma L929 cells do not require caspase inhibition to undergo
TNF-mediated necroptosis, rendering these cells of particular
interest for the in vitro study of necroptosis. Nevertheless, L929
cells retain the ability to undergo apoptosis, and switches to TNF-
mediated apoptosis have been reported when components of
the necroptotic machinery are repressed,19,20 L929 cells also
activate the intrinsic apoptotic pathway when stimulated with
apoptosis-inducing agents such as staurosporine.21
In this study, we investigated the cell deathmodality induced
by sustained ER stress in the L929 cell line, a cellular model for
both apoptosis and necroptosis induction. In these cells, we
found that ER stress induction by chemical triggers such as
brefeldin A, thapsigargin and tunicamycin did not activate the
intrinsic apoptotic pathway but instead triggered TNFR1-
mediated necroptosis. Remarkably, TNFR1 signaling was
independent of the autocrine production of the receptor’s
cognate ligands TNF and lymphotoxin α (LTα). In addition, we
found that chemical inhibition of RIPK1 kinase activity by
necrostatin-1 (Nec-1) protected the cells from death, while
repressing RIPK1, mixed lineage kinase domain-like protein
(MLKL) or TNFR1 levels induced a switch in the cell death
modality, from necroptosis to apoptosis. Taken together, these
results highlight the ability of ER stress to trigger cell death
modalities other than apoptosis, and identified Nec-1 as a
potential new compound for the treatment of pathologies
resulting from unresolved ER stress-mediated death.
Results
ER stress induces caspase-independent necroptosis in
L929sA cells. To determine the cell death modality induced
by sustained ER stress in the L929sA cell line, we stimulated
the cells with three different compounds reported to be strong
inducers of ER stress, namely brefeldin A, thapsigargin and
tunicamycin. ER stress induction by these compounds was
confirmed by monitoring the expression of several ER
stress markers, such as spliced XBP-1, Grp78 and CHOP
(Supplementary Figure S1). We observed that each
compound triggered death of the L929sA cells in a
dose-dependent manner (Figures 1a–c), and that ~ 30–50%
of cell death was obtained after 24 h of stimulation with the
different compounds used at the respective concentration of
0.5 μg/ml, 2.5 μM and 2.5 μg/ml (Figure 1d). A comparable
amount of cell death was obtained by stimulating the cells
with either 30 ng/ml of TNF for 4 h or with 10 nM of
staurosporine for 24 h, two triggers, respectively, used as
positive controls for necroptosis and apoptosis induction in
these cells (Figures 1e and f). To evaluate whether the death
induced by the different ER stressors was relying on caspase
activation, we monitored processing of caspase-9 and -3 as
well as cleavage of the caspase-3 substrate PARP by
immunoblotting cell lysates obtained after stimulating the
cells with 0.5 μg/ml of brefeldin A, 2.5 μM of thapsigargin and
2.5 μg/ml of tunicamycin over a period of 24 h. Similarly to
TNF stimulation and contrary to staurosporine treatment,
none of the ER stress inducers lead to caspase activation
(Figure 1g), which was confirmed by DEVDase assays
performed on lysates collected 24 h after stimulation
(Figure 1h). In line with these results, pre-treatment with
the pancaspase inhibitor Boc-D-FMK protected the cells
from staurosporine-mediated killing but not from brefeldin
A- or TNF-induced death (Figure 1i). To test whether the
caspase-independent death caused by the administration of
the ER stressors could result from necroptosis induction, we
next evaluated the potential protective effect of inhibiting
RIPK1 kinase activity with Nec-1. As shown in Figure 1j,
RIPK1 kinase inhibition protected L929sA cells from brefeldin
A-induced death as efficiently as following TNF stimulation,
but had no effect on staurosporine-mediated killing. We
confirmed these results using the more stable and specific
RIPK1 inhibitor, Nec-1s (Supplementary Figure S2). Taken
together, these results demonstrate that ER stress induces
RIPK1 kinase-dependent necroptosis in L929 cells.
RIPK1 repression shifts ER stress-induced necroptosis
to ER stress-induced apoptosis. To further characterize
the role of RIPK1 during ER stress-induced death, we stably
repressed RIPK1 expression in L929sA cells. Surprisingly,
and in contrast to the Nec-1 effect, we found that RIPK1
knockdown did not protect the cells from brefeldin
A-mediated death (Figure 2a). In the context of TNF
signaling, we previously reported that, contrary to Nec-1,
RIPK1 repression does not protect L929sA cells from TNF
cytotoxicity but instead sensitized them by allowing a switch
from necroptotic to apoptotic death.19,20 We therefore
wondered whether a similar mechanism was occurring upon
ER stress induction. To test this hypothesis, we monitored
caspase activation by immunoblot and DEVDase assays in
lysates of control and RIPK1-depleted L929sA cells stimu-
lated with brefeldin A, or TNF used as a control. We found
that RIPK1 knockdown resulted in the induction of caspase
activation both following TNF and brefeldin A stimulation
(Figures 2b and c). Interestingly, although Boc-D-FMK was
very efficient in inhibiting caspase activation (Figure 2b), it did
not protect RIPK1-depleted cells from brefeldin A treatment
and only had a limited protective effect following TNF
stimulation (Figure 2a). Because a switch back to RIPK3-
dependent necroptosis was reported in RIPK1-depleted
L929sA cells stimulated with TNF in the presence of
caspase-8 repression,19 we next investigated the effect of
additional RIPK3 depletion on the death of RIPK1-repressing
cells stimulated with brefeldin A and Boc-D-FMK. As shown
in Figures 2d and e, additional RIPK3 depletion did not
protect RIPK1-depleted L929sA cells from brefeldin A used
alone but greatly rescued them under caspase-inhibited
conditions. As expected, RIPK3 knockdown also provided
further protection to the RIPK1-depleted L929sA cells
stimulated with TNF and Boc-D-FMK (Figure 2d). Taken
together, these results highlight the high similarities in the
death pathways activated by TNF and ER stress inducers in
L929sA cells.
MLKL serves as an effector of ER stress-induced
necroptosis. MLKL recently emerged as a key molecule
mediating necroptosis downstream of RIPK3.22–25 To test
whether MLKL has a role in necroptosis triggered by ER
stress inducers in L929sA cells, we transfected the cells with
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MLKL or control siRNA (Figure 3a) and monitored cell
viability upon BFA treatment. Interestingly, MLKL repression
also resulted in a switch from necroptosis to apoptosis, which
was observed by the loss of protective effect of Nec-1 and the
gain of protection offered by Boc-D-FMK (Figure 3b). There-
fore, contrary to RIPK1, MLKL repression did not allow a
switch back to RIPK3-dependent necroptosis in caspase-
inhibited conditions. The switch to apoptosis was confirmed
by the analysis of caspase-9 and -3 processing by western
blot (Figure 3c). As reported previously,20 we observed that
MLKL repression also induced a switch to apoptosis when
stimulating L929sA cells with TNF. Taken together, these
results further support activation of the same necroptotic
cascade between TNF stimulation and ER stress induction in
these cells.
TNFR1 mediates ER stress-induced necroptosis. Owing
to the strong similarities in the killing of L929sA cells by TNF
and ER stress inducers, we wondered whether the death
induced by ER stress in these cells would not actually be
Figure 1 ER stress induces necroptosis in L929sA cells. (a–f) L929sA cells were treated with increasing concentrations of brefeldin A (BFA) (a), thapsigargin (Tg) (b) and
tunicamycin (Tm) (c) for 24 h, with 0.5 μg/ml of BFA, 2.5 μM of Tg and 2.5 μg/ml of Tm over a period of 36 h (d) or with 30 ng/ml of human TNF (hTNF) (e) up to 8 h or with 10 nm
of staurosporine (St) up to 36 h (f), and the percentage of cell death was determined by flow cytometry following Sytox Red staining. (g) Immunoblots of cell lysates isolated
following treatment with 0.5 μg/ml of BFA, 2.5 μg/ml of Tm and 2.5 μM of Tg for the indicated period, as well as with 10 nM of St (24 h) and 30 ng/ml of hTNF (4 h). (h) Caspase-3
activity measured by DEVD-AMC assay after 24 h of treatment with 0.5 μg/ml of BFA, 2.5 μg/ml of Tm and 2.5 μM of Tg, as well as after 24 h with 10 nM of St and 4 h with
30 ng/ml of hTNF. (i and j) Cell death evaluated by flow cytometry after Sytox Red staining of L929sA stimulated with 0.5 μg/ml of BFA (24 h), 10 nM of St (24 h) and 30 ng/ml of
hTNF (4 h) in the absence and presence of 10 μM of Boc-D-FMK (i) or 20 μM of Nec-1 (j). PARP, poly-ADP ribose polymerase
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mediated by TNF itself. Previous studies have indeed
reported NF-κB-mediated autocrine production of TNF upon
ER stress induction in certain cells.26 We therefore first
evaluated this possibly by testing the effect of TNFR1
repression on ER stress-induced death. Although not
complete, the extent of TNFR1 knockdown that we obtained
was sufficient to protect the cells from TNF-induced
necroptosis, but had no significant protective effect on
brefeldin A cytotoxicity (Figures 4a and b). Nevertheless, the
finding that Nec-1 had lost its protective effect in these cells
raised the possibility of a switch to another, RIPK1 kinase-
independent, cell death modality (Figure 4a). This assump-
tion was confirmed when analyzing caspase activation by
immunoblot and DEVDase assays. We observed that
TNFR1 repression induced a switch from RIPK1 kinase
activity-dependent necroptosis to RIPK1 kinase-independent
Figure 2 RIP1K1 repression shifts ER stress-induced necroptosis to ER stress-induced apoptosis. (a) Control (Ctrl) and RIPK1-depleted (miRIPK1) L929sA cells were
treated for 24 h with 0.5 μg/ml of brefeldin A (BFA) or 2–4 h with 30 ng/ml of human TNF (hTNF) (Ctrl cells were stimulated for 4 h and RIPK1-depleted cells for 2 h to induce a
comparable amount of cell death), alone or in combination with 10 μM of Boc-D-FMK, and viability was evaluated by flow cytometry following Sytox Red staining. (b) Immunoblots
of cell lysates of Ctrl and RIPK1-depleted L929sA cells isolated following treatment for 24 h with 0.5 μg/ml of BFA or 2–4 h with 30 ng/ml of hTNF (Ctrl cells were stimulated for 4 h
and RIPK1-depleted cells for 2 h to induce a comparable amount of cell death), alone or in combination with 10 μM of Boc-D-FMK. (c) Caspase-3 activity in Ctrl and RIPK1-
depleted L929sA cells measured by DEVD-AMC assay after 24 h of treatment with 0.5 μg/ml of BFAA as well as after 2–4 h of treatment with 30 ng/ml of hTNF (Ctrl cells were
stimulated for 4 h and RIPK1-depleted cells for 2 h to induce a comparable amount of cell death). (d) RIPK1-depleted (Ctrl/miRIPK1) and RIPK1/RIPK3-depleted (miRIPK1/
shRIPK3) L929sA cells were treated for 24 h with 0.5 μg/ml of BFA alone or in combination with 10 μM of Boc-D-FMK, and the cell viability was evaluated by flow cytometry after
Sytox Red staining. Cells were also treated with 30 ng/ml of hTNF (2 h). (e) Lysates from Ctrl and RIPK1- and RIPK1/RIPK3-depleted L929sA cells probed for RIPK1 and RIPK3
to validate the efficiency of the knockdowns. Actin was used as a loading control. PARP, poly-ADP ribose polymerase
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apoptosis following ER stress induction by brefeldin A or
thapsigargin treatment (Figures 4c–e). Importantly, the
apoptotic cell death was fully prevented when costimulating
the TNFR1-repressing cells with the caspase inhibitor Boc-D-
FMK (Figure 3a). These findings therefore demonstrate that
TNFR1 is the upstream mediator of necroptosis in L929sA
cells undergoing unresolved ER stress, and illustrate the
ability of these cells to still switch to apoptosis when TNFR1
signaling is inhibited at the level of the receptor itself.
TNFR1 mediates ER stress-induced necroptosis inde-
pendently of ligand binding. Having established that ER
stress kills L929 cells by triggering TNFR1-mediated
necroptosis, we next examined whether the killing was
occurring as a result of autocrine TNF production. To do so,
we first analyzed by ELISA the ability of L929sA cells to
secrete soluble TNF following ER stress induction. We
found that stimulation with brefeldin A over a period of 24 h
did not induce detectable levels of soluble TNF in the cell
medium (Figure 5a). By contrast, LPS stimulation, a known
inducer of TNF secretion, leads to detectable amounts of
TNF in the medium (Figure 5a). To further exclude a role of
extracellular TNF, we next incubated the cells with a TNF-
blocking antibody before ER stress induction. As shown in
Figure 5b, the addition of the TNF-blocking antibody did not
affect brefeldin A or thapsigargin cytotoxicity, but efficiently
blocked cell death induced by exogenous TNF. Because
export of secreted proteins is most probably greatly affected
under severe ER stress conditions, we hypothesized that
activation of TNFR1 by its ligands could alternatively occur
in intracellular compartments. Apart from TNF, lymphotoxin
α (LΤα) was recently reported to be as potent as TNF in
mediating apoptosis, necroptosis and inflammatory
signals.27 We therefore analyzed the transcriptional
upregulation of the genes encoding these two TNFR1
ligands by Q-PCR analysis. As shown in Figure 5c,
brefeldin A treatment resulted in the upregulation of both
TNF and LTα mRNA transcripts, and therefore still support-
ing a potential role of their encoded proteins in ER stress-
induced death. We then analyzed the effect of repressing
TNF and LΤα on the killing potential of brefeldin A. The
efficacy of TNF and LΤα knockdown was confirmed at the
mRNA level by Q-PCR (Figure 5d) and at the protein level
by western blotting for TNF (Figure 5f). We found that TNF
and LΤα repression had no effect on brefeldin A cytotoxicity
when compared with nonspecific siRNA treatment
(Figure 5e). Importantly, we confirmed that the lack of
protective effect was not due to a switch to RIPK1 kinase-
independent apoptosis, as observed upon TNFR1 repres-
sion. Indeed, contrary to TNFR1-depleted cells (Figure 4),
brefeldin A treatment did not induce caspase activation in
the TNF- and LTα-depleted cells (Figure 5f). Accordingly,
these cells were still protected by Nec-1, while Boc-D-FMK
had no effect on their viability (Figure 5e). These results
clearly demonstrate that ER stress induces TNFR1-
mediated necroptosis in L929sA cells independently of
ligand binding.
Role of the JNK pathway in ER stress-mediated cell
death. It has previously been suggested that ER stress
could kill by activating a TRAF2/JNK pathway,2 and that
RIPK1 was required for JNK activation by interacting with
TNFR1.28 Knowing the contribution of JNK to both
apoptotic29 and caspase-independent mode of cell death,30
we therefore evaluated the role of the JNK pathway in our
cellular model. To do so, we applied SP600125, an inhibitor of
JNK-1, -2 and -3,31 in combination with BFA or TNF treatment
in L929sA cells and evaluated its effect on the viability of the
Figure 3 Role of MLKL in ER stress-induced necroptosis. (a) Levels of MLKL mRNA after short interfering RNA (siRNA)-mediated knockdown. (b) L929sA cells were treated
for 24 h with 0.5 μg/ml of brefeldin A (BFA) alone or in combination with 20 μM of Nec-1 or 10 μM of Boc-D-FMK, and viability was evaluated by flow cytometry following Sytox Red
staining. (c) L929sA cells transfected with control (Ctrl) and MLKL siRNAs were lysed after treatment for 24 h with 0.5 μg/ml of BFA or with 30 ng/ml of human TNF (hTNF) (4 h)
and expression of apoptotic markers was analyzed by western blot
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cells. We observed that SP600125 successfully inhibited
phosphorylation of JNK, as well as its downstream target
c-Jun, in response to both BFA and TNF (Figure 6a), and
provided partial protection to necroptosis induced by both
triggers (Figure 6b). Importantly, we observed that JNK
activation was a result of TNFR1 signaling following BFA and
TNF treatments. Indeed, TNFR1 repression by shRNA
prevented BFA- and TNF-mediated phosphorylation of JNK
and c-Jun (Figure 6c), and resulted in the loss of the
protective effect of SP600125 (Figure 6d). Nevertheless, we
found that RIPK1 was not required for JNK activation
(Figure 6e), and consequently that SP600125 also provided
partial protection to apoptosis induced by TNF and BFA in the
RIPK1-repressing cells (Figure 6f). Taken together, these
results indicate that ER stress induction in L929sA cells
activates ligand-independent TNFR1 signaling that mediates
both RIPK1/RIPK3/MLKL-dependent necroptosis and RIPK1-
independent JNK-dependent death.
Figure 4 Involvement of TNFR1 in ER stress induced cell death. (a) Control (Ctrl) and TNFR1-depleted (shTNFR1) L929sA cells were treated for 24 h with 0.5 μg/ml of
brefeldin A (BFA) alone or in combination with 20 μM of Nec-1 or 10 μM of Boc-D-FMK, and viability was evaluated by flow cytometry following Sytox Red staining. Functionality of
the knockdown was confirmed after treatment with human TNF (hTNF). (b) Knockdown of TNFR1 was validated by reverse transcription-PCR (RT-PCR) with specific primers.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an endogenous control. (c) Immunoblots of Ctrl and TNFR1-depleted L929sA cells lysates isolated after
treatment for 24 h with 0.5 μg/ml of BFA or with 30 ng/ml of hTNF (4 h). (d) Caspase-3 activity in Ctrl and TNFR1-depleted L929sA cells measured by DEVD-AMC assay after 24 h
of treatment with 0.5 μg/ml of BFA alone or in combination with 10 μM of Boc-D-FMK. (e) Immunoblots of Ctrl and TNFR1-depleted L929sA cell lysates isolated after treatment for
24 h with 2.5 μM of thapsigargin (Tg) or with 30 ng/ml of hTNF (4 h). PARP, poly-ADP ribose polymerase
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Discussion
Cell death is a crucial process for multicellular organisms, as it
ensures proper morphogenesis, establishment of the immune
system, elimination of damaged cells and maintenance of
homeostasis. As a consequence, cell death needs to be tightly
regulated because inappropriate cell death responses inexor-
ably lead to the development of pathologies. In humans, these
include neurodegenerative disorders, autoimmune diseases,
diabetes and cancers. Apoptosis, a process relying on the
activation of the caspase cascade, has long been considered
the only form of regulated cell death, but existence of additional
forms of controlled cell death is nowwell established.32,33 These
can be triggered independently of apoptosis induction or as
back-up safety mechanisms in situations where the apoptotic
machinery does not operate properly, such as a result of genetic
mutations or chemical/microbial inhibition.
Necroptosis, or programmed/regulated necrosis, is a non-
apoptotic, caspase-independent, inflammatory type of cell
death that relies on the enzymatic activity of RIPK1/3 and on
the pseudokinase MLKL.14,15 Necroptosis has attracted a lot
of attention lately because of its demonstrated role as
alternative cell death modality during infection,34 as well as
for its contribution to the pathogenesis of several human
Figure 5 Role of TNFR1 ligands in ER stress-induced necroptosis. (a) The release of TNF in the medium after treatment with 0.5 μg/ml of brefeldin A (BFA) for indicated time
points was measured by enzyme-linked immunosorbent assay (ELISA). As a control, L929sA cells were also treated with 0.01 μg/ml of lipopolysaccharide (LPS) for 24 h. Mouse
TNF standard was used for the standard curve. (b) L929sA cells were treated with 20 ng/ml of mTNF (12 h), 0.5 μg/ml of BFA (24 h) or 2.5 μM of thapsigargin (Tg) (24 h) in the
presence or absence of 12 ng/ml of TNF-blocking antibody. Viability was evaluated by flow cytometry following Sytox Red staining. (c) The induction of TNF and LTα mRNAs
following treatment with 0.5 μg/ml of BFA for the indicated period of time was evaluated by quantitative PCR (Q-PCR) analysis. (d) Levels of TNF and LTα mRNA after short
interfering RNA (siRNA)-mediated knockdown. (e) Control (Ctrl), TNF-depleted (siTNF) and LTα-depleted (siLTα) L929sA cells were stimulated for 24 h with 0.5 μg/ml of BFA in
the absence or presence of 20 μM of Nec-1 or 10 μM of Boc-D-FMK, and cell viability was evaluated by flow cytometry following Sytox Red staining. (f) Immunoblots of Ctrl, TNF-
depleted and LTα-depleted L929sA cell lysates isolated after treatment for 24 h with 0.5 μg/ml of BFA or 4 h with 30 ng/ml of human TNF (hTNF). Cells treated with 10 nM of
staurosporine were used as Ctrl for apoptosis induction. NS, not significant; PARP, poly-ADP ribose polymerase
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diseases, such as ischemic brain injury, myocardial infarction
and stroke, renal ischemia–reperfusion injury, pancreatitis and
inflammatory bowel diseases (for a review see Linkermann
and Green14 and Vanlangenakker et al.35). Interestingly,
conditions such as infection and hypoxia–ischemia are
physiological ER stress inducers, and ER stress-induced
cellular dysfunction and death have been associated with
diseases that are known to be mediated, at least in part, by
necroptosis.6,7 However, whether ER stress could directly
trigger necroptosis had remained an open question. Indeed,
studies in the ER stress field have so far mainly focused on the
the ability of ER stress to kill by activating the intrinsic apoptotic
pathway.4 In this study, we provide clear evidence that
unresolved ER stress, induced by three different compounds,
can also result in necroptosis induction, thus highlighting a
potential molecular link between ER stress, necroptosis and
the establishment of those diseases. In addition, the fact that
ER stress can trigger an inflammatory type of cell death, which
contrasts with apoptosis that is in many conditions immuno-
silent, opens doors for future studies on the role of ER stress in
inflammation-driven pathologies.
In our cellular system, the L929sA cell line, we found that ER
stress-induced necroptosis was mediated by TNFR1, which is
in line with earlier studies implicating TNFR1 signaling in the
cellular response to ER stress.26,28 As previously reported
following TNF stimulation,19 we observed that RIPK1 kinase
inhibition byNec-1, or Nec-1s, protected L929sA cells fromER
stress cytotoxicity while RIPK1 repression induced a switch to
apoptosis. The plasticity in the cell death modality used was
further highlighted by the switch back to RIPK1-independent
Figure 6 Role of JNK inhibition in ER stress-induced cell death. (a and b) L929sA cells and (c and d) control (Ctrl) and shTNFR1 L929sA cells were stimulated for 24 h with
0.5 μg/ml of brefeldin A (BFA) or 4 h with 30 ng/ml of human TNF (hTNF) in the absence or presence of 20 μM of SP600125. (a and c) Cell lysates were immunoblotted as
indicated and (b and d) cell viability was evaluated by flow cytometry following Sytox Red staining. (e and f) Control (Ctrl) and miRIPK1 L929sA cells stimulated for 24 h with
0.5 μg/ml of brefeldin A or with 30 ng/ml of hTNF (Ctrl cells were stimulated for 4 h and RIPK1-depleted cells for 2 h to induce a comparable amount of cell death) in the absence or
presence of 20 μM of SP600125. (e) Cells lysates were immunoblotled as indicated and (f) cell viability was evaluated by flow cytometry following Sytox Red staining
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necroptosis when caspaseswere additionally inhibited. Indeed,
RIPK1-depleted L929sA cells could only be rescued from ER
stress-induced death by the combination of caspase inhibition
and RIPK3 repression. In contrast, MLKL repression induced a
switch to apoptosis that could be inhibited by caspase inhibition,
highlighting the more downstream role of MLKL in the
necroptotic cascade. Importantly, the ability of the cells to adapt
to an alternative cell death route was not only observed upon
repression of a downstream executioner but also when knock-
ing down the receptor itself. Indeed, a switch from necroptosis to
apoptosis was also detected upon TNFR1 repression. Taken
together, the results highlight the difficulty to block cell death
under ER stress conditions owing to the ability of the cells to
circumvent blockade of one specific pathway by activating
alternative death routes. These findingsare ofmajor importance
for the success of therapeutic strategies aimed at inhibiting ER
stress-mediated death. In this context, our results show that
Nec-1 is a good candidate, as the allosteric inhibition of RIPK1
kinase activity does not allow a switch to another death mode.
Moreover, these results also highlight the importance of proper
cell death typing when evaluating the contribution of certain
proteins in the death induced by ER stress.
Surprisingly, we found, using blocking antibody and RNAi
approaches, that signaling by TNFR1 during ER stress was
occurring independently of ligand binding. These results are in
contrast with those from Hu et al.26 who suggested a model of
ER stress-induced TNFR1 activation resulting from IRE1-
mediated NF-κB-dependent autocrine production of TNF.26
Nevertheless, our results support the study of Yang et al.,28
which suggested ligand-independent activation of TNFR1 at
the ER membrane during ER stress.28 Interestingly, ligand-
independent signaling by TNFR1 at the ER was also recently
reported in the case of TNF receptor-associated periodic
syndrome (TRAPS), an autosomal-dominant autoinflamma-
tory disease associated with heterozygous mutations in
TNFR1.36 In this study, the authors showed that TRAPS-
associated mutant TNFR1 molecules are retained in the ER
and unable to bind TNF but still capable of signaling to NF-κB
and to cell death. Of note, in our study, it is unknown whether
the ER stress-induced ligand-independent TNFR1 signaling
originates at the plasmamembrane or intracellularly. However,
knowing that severe ER stress conditions alter export of
membrane proteins, it is reasonable to speculate that it also
originates from intracellular compartments, and potentially
from the ER. Of note, ER stress-induced ligand-independent
DR5-mediated apoptosis has recently been reported in other
cell types.37 This demonstrates the ability of ER stress to
trigger ligand-independent activation of death receptors,
whose identity may vary depending on the cell type.
Finally, we observed that activation of TNFR1 by ER stress
or TNF stimulation in L929sA cells resulted in JNK activation,
which partially contributed to necroptosis induced by these
triggers. In contrast to the results of Yang et al.,28 we found that
RIPK1 repression had no impact on JNK activation, and that
JNK inhibition still provided protection to apoptosis resulting
from RIPK1 repression in these cells. The fact that JNK
inhibition provided protection to both TNFR1-induced necrop-
tosis and apoptosis is intriguing, and suggest a rather
aspecific role of JNK in cell death induction in these cells.
In conclusion, our study reveals the ability of ER stress to
trigger RIPK1 kinase-dependent necroptosis, which opens
new doors for future work on the implication of ER stress in
pathologies resulting from the inappropriate induction of this
inflammatory type of cell death.
Materials and Methods
Cell culture and reagents. L929sA cells were cultured in Dulbecco’s modified
Eagle’s medium (Sigma-Aldrich, St. Louis, MO, USA; D6429) with 10% (v/v) fetal
bovine serum, 1% (v/v) penicillin–streptomycin (Sigma-Aldrich; P0781) and 2 mM
L-glutamine (Sigma-Aldrich; G7513). HEK293T cells used for the viral production were
grown in the same media but without the L-glutamine supplement. Cells were cultured
in a humidified incubator at 37 °C with a 5% CO2 concentration. The reagents used
for the treatments were as follows: human TNF (Immunotools, Friesoythe, Germany;
no. 11343017), staurosporine (Sigma-Aldrich; no. S6942), brefeldin A (Sigma-Aldrich;
no. B7651), tunicamycin (Sigma-Aldrich; no. T7765), thapsigargin (Sigma-Aldrich; no.
T9033), Boc-D-FMK (Cambridge Bioscience, Cambridge, UK; no. 1120-20C), Nec-1
(Santa Cruz Biotechnology, Dallas, TX, USA; no. CAS 4311-88-0), RIP1 inhibitor II,
7-Cl-O-Nec-1 (Nec-1s) (Merck, Darmstadt, Germany; no. 504297) and SP600125
(Sigma-Aldrich; no. S5567). Recombinant mouse TNF is produced and purified to at
least 99% homogeneity in our laboratory. The antibodies used in the study were as
follows: PARP (CST, Danvers, MA, USA; no. 9542), caspase-9 (CST; no. 9508),
cleaved caspase-3 (CST; no. 9665), actin (Sigma-Aldrich; no. A2066), RIPK1 (BD
Transduction Laboratories, Franklin Lakes, NJ, USA; no. 610459), RIPK3
(Sigma-Aldrich; no. R4277), TNF (Santa Cruz Biotechnology; no. sc-52746), c-Jun
(Santa Cruz Biotechnology; no. sc-1694), phospho-c-Jun (Santa Cruz Biotechnology;
no. sc-822), SAPK/JNK (CST; no. 9252) and phospho-SAPK/JNK (CST; no. 9251).
All the secondary antibodies were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA) and the signal was visualized using Western Lightning ECL
substrates (Perkin-Elmer, Waltham, MA, USA). The TNF-blocking antibody comes
from Bioceros BV (Utrecht, Netherland; no. XT-22). The mouse TNF ELISA Kit was
purchased from eBioscience (San Diego, CA, USA; no. 88-7324-22) and used
according to the manufacturer’s protocol.
Gene repression. Control, miRIPK1 and miRIPK3 L929sA cells were generated
as described previously.38 pLKO lentiviral control and shRNA vector against mouse
TNFR1 (TRCN0000066103) were obtained from Sigma-Aldrich. Lentivirus production
was obtained by co-transfecting the lentiviral plasmids with the second-generation
lentivirus packaging system (Addgene, Cambridge, MA, USA; pMD2.G cat. no. 12259,
psPAX2 cat. no.12260, pRSV-Rev cat. no. 12253) using JET PEI transfection reagent
(Polyplus Transfection, Illkirch, France; cat. no. 101-01N) into HEK293T cells. Virus-
containing supernatant was harvested and filtered through 0.22 μm filter. Transduction
was performed in the presence of 5 μg/ml of polybrene (Merck Millipore, Darmstadt,
Germany; TR-1003-G). Control and shTNFR1 cells were selected for 72 h in 5 μg/ml
of puromycin. TNF (L-042302-00-0005), LTα (L-043958-00-0005) and nonspecific
(D-001810-01-20) siRNAs were purchased from Dharmacon (Thermo Fisher
Scientific, Waltham, MA, USA). siRNA transfection was performed using INTERFERin
(Polyplus Transfection; no. 409-50) according to the manufacturer’s protocol.
RNA extraction, RT-PCR and Q-PCR. RNA was extracted using the
TRIzol reagent (Sigma-Aldrich; no. T9424), precipitated with ethanol and reverse
transcribed using the superscript III following the manufacturer’s protocol
(Invitrogen, Waltham, MA, USA). The obtained cDNA was used as template for
the PCR reactions using the following primers: GAPDH (forward primer: 5′-ACCACAG
TCCATGCCATC-3′; reverse primer: 5′-TCCACCACCCTGTTGCTG-3′) and TNFR1
(forward primer: 5′-CAGTCTGCAGGGAGTGTGAA-3′; reverse primer: 5′-CACGCA
CTGGAAGTGTGTCT-3′) (Integrated DNA Technologies, Coralville, IA, USA).
Q-PCR was performed using Brilliant III Ultra-Fast Q-PCR Master Mix (Agilent,
Santa Clara, CA, USA) according to the manufacturer’s protocol. Relative gene
expression was evaluated by ΔΔCT method and GAPDH was used as the
housekeeping gene to normalize gene expression. Probes were purchased from
Integrated DNA Technologies and were as follows: GAPDH (forward primer:
5′-GCCTTCCGTGTTCCTACC-3′; reverse primer: 5′-CCTCAGTGTAGCCCAAGAT
G-3′), LTα (forward primer: 5′-TCTCCAGAGCAGTGAGTTCT-3′; reverse primer:
5′-CTCAGAAGCACTTGACCCAT-3′), TNF (forward primer: 5′-TCTTTGAGA
TCCATGCCGTTG-3′; reverse primer: 5′-AGACCCTCACACTCAGATCA-3′) and
MLKL (forward primer: 5′-TCTCTCTGCTTTAGTGCTCTTTG-3′; reverse primer:
5′-CAGCTCCAGTTTCCTCGTAG-3′).
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DEVDase assay. Following stimulation, the cells were trypsinized, pelleted,
washed once with PBS and resuspended in 50 μl of ice-cold PBS. Samples were
then snap-frozen in duplicate and kept at − 80 °C until further processing. On the
day of the assay, the samples were diluted in the assay buffer (100 mM HEPES,
10% sucrose and 0.1% CHAPS) in the presence of a final concentration of 50 μM of
Ac-Asp-Glu-Val-Asp-α-(4-methyl-coumaryl-7-amide) (Peptide Institute Inc., Osaka,
Japan; cat. no. 3171-v), 0.0001% NP-40 and 5 μM of DTT. The samples were
then read at 355 nm excitation and 460 nm emission on a preheated plate reader
(at 37 °C) for 30 cycles with 1 min intervals.
Cell death analysis. Following stimulation, the cells were trypsinized, pelleted,
resuspended in PBS containing 5 nM of Sytox Red (Invitrogen; no. S34859)
and incubated for 15 min on ice. The cells were then analyzed for Sytox Red positivity
using the BD FACs Canto Flow Cytometer (BD Bioscience, Franklin Lakes, NJ, USA).
The percentage of cell death is calculated as follows: % cell death= (no. of Sytox Red+/
(no. of Sytox Red++no. of Sytox Red−)) × 100.
Statistical analysis. Experiments were repeated independently at least three
times. Error bars represent the standard deviation (S.D.) of replicates. Statistical
analyses were performed using unpaired Student’s t-tests using the GraphPad
Software (San Diego, CA, USA) (*Po0.05, **Po0.01 and ***Po0.001).
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